{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T19:40:08Z","timestamp":1749325208041,"version":"3.41.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Major depressive disorder is a common mood disorder and presents increased morbidity and mortality risks for patients with comorbid cardiovascular disease (CVD). Selective serotonin reuptake inhibitors (SSRIs) are a cornerstone of treatment for major depressive disorder, given their relative safety and affordability compared with other antidepressant classes, and SSRIs frequently are used in patients with CVD. However, clinicians should carefully weigh safety considerations before prescribing SSRIs in these patients. This article reviews the safety of SSRIs in patients with CVD and discusses SSRI selection.<\/jats:p>","DOI":"10.1097\/01.jaa.0000735792.92508.a6","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T16:15:48Z","timestamp":1616084148000},"page":"18-19","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Which SSRI is safest for patients with CVD and major depressive disorder?"],"prefix":"10.1097","volume":"34","author":[{"given":"Sabrina","family":"Dunham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Lucy","family":"Wilkening","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas C.","family":"Schwier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"11 suppl 2","key":"R1-20250607","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.amjmed.2008.09.010","article-title":"Depression in patients with coronary heart disease","volume":"121","author":"Carney","year":"2008","journal-title":"Am J Med"},{"issue":"8","key":"R2-20250607","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2006.06.055","article-title":"Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes","volume":"48","author":"Rutledge","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"R3-20250607","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0006-3223(03)00587-0","article-title":"Epidemiology of comorbid coronary artery disease and depression","volume":"54","author":"Rudisch","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"4","key":"R4-20250607","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.297.4.367","article-title":"Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial","volume":"297","author":"Lesp\u00e9rance","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"R5-20250607","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.288.6.701","article-title":"Sertraline treatment of major depression in patients with acute MI or unstable angina","volume":"288","author":"Glassman","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"R6-20250607","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/00006842-200011000-00007","article-title":"Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial","volume":"62","author":"Strik","year":"2000","journal-title":"Psychosom Med"},{"issue":"9","key":"R7-20250607","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2010.03.068","article-title":"Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial","volume":"56","author":"O'Connor","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"R8-20250607","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1001\/jama.2016.7635","article-title":"Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial","volume":"315","author":"Angermann","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"R9-20250607","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1345\/aph.1G293","article-title":"Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults","volume":"40","author":"Jacob","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"6","key":"R10-20250607","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.psym.2014.01.010","article-title":"Antidepressants and the risk of hyponatremia: a class-by-class review of literature","volume":"55","author":"De Picker","year":"2014","journal-title":"Psychosomatics"},{"issue":"1","key":"R11-20250607","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.ajkd.2016.08.020","article-title":"Second-generation antidepressants and hyponatremia risk: a population-based cohort study of older adults","volume":"69","author":"Gandhi","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"R12-20250607","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjmed.2017.07.025","article-title":"Differences in associations of antidepressants and hospitalization due to hyponatremia","volume":"131","author":"Farmand","year":"2018","journal-title":"Am J Med"},{"issue":"8","key":"R13-20250607","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/eurheartj\/ehl542","article-title":"Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry","volume":"28","author":"Gheorghiade","year":"2007","journal-title":"Eur Heart J"},{"issue":"5","key":"R14-20250607","first-page":"470","article-title":"Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability","volume":"25","author":"Gury","year":"1999","journal-title":"Encephale"},{"issue":"1","key":"R15-20250607","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psym.2012.11.001","article-title":"QTc prolongation, torsades de pointes, and psychotropic medications","volume":"54","author":"Beach","year":"2013","journal-title":"Psychosomatics"},{"issue":"10","key":"R16-20250607","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1177\/1060028013501994","article-title":"A comparison of the risk of QT prolongation among SSRIs","volume":"47","author":"Funk","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"12","key":"R17-20250607","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1177\/1060028014550645","article-title":"Risk of QT\/QTc prolongation among newer non-SSRI antidepressants","volume":"48","author":"Jasiak","year":"2014","journal-title":"Ann Pharmacother"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"f288","DOI":"10.1136\/bmj.f288","article-title":"QT interval and antidepressant use: a cross sectional study of electronic health records","volume":"346","author":"Castro","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"R19-20250607","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.amjmed.2005.03.044","article-title":"Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something","volume":"119","author":"Serebruany","year":"2006","journal-title":"Am J Med"},{"issue":"8","key":"R20-20250607","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.0000085163.21752.0A","article-title":"Platelet\/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy","volume":"108","author":"Serebruany","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"R21-20250607","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/FTD.0b013e318224996e","article-title":"Bleeding incidence with concomitant use of antidepressants and warfarin","volume":"33","author":"Cochran","year":"2011","journal-title":"Ther Drug Monit"},{"issue":"16","key":"R22-20250607","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1503\/cmaj.100912","article-title":"Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction","volume":"183","author":"Labos","year":"2011","journal-title":"CMAJ"},{"issue":"1","key":"R23-20250607","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1389200023338017","article-title":"Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update","volume":"3","author":"Hemeryck","year":"2002","journal-title":"Curr Drug Metab"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000735792.92508.a6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T19:01:18Z","timestamp":1749322878000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000735792.92508.a6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000735792.92508.a6","relation":{},"ISSN":["1547-1896"],"issn-type":[{"type":"print","value":"1547-1896"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}